Suppr超能文献

甲状腺功能障碍在危重病患者中的作用:文献复习。

The role of thyroid dysfunction in the critically ill: a review of the literature.

机构信息

Department of Anesthesiology and Intensive Care, Sacro Cuore Catholic University, A. Gemelli Hospital, Rome, Italy.

出版信息

Minerva Anestesiol. 2010 Nov;76(11):919-28. Epub 2010 Oct 8.

Abstract

During critical illness, patients with no known history of thyroid disorders may experience multiple alterations in their serum thyroid hormone levels. Such alterations have been termed sick euthyroid syndrome or, more recently, non-thyroidal illness syndrome (NTIS). The laboratory parameters of NTIS usually include low serum levels of triiodothyronine (T3), normal or low serum levels of thyroxine (T4) and normal or low serum levels of thyroid-stimulating hormone (TSH). The magnitude of the alteration in thyroid function correlates with the severity of the illness and its outcomes in critically ill patients with NTIS. The pathogenetic mechanisms involved in NTIS include a decreased conversion of T4 to T3 in extrathyroidal tissues and alterations in thyroid hormones' binding to serum proteins. In cases of protracted critical illness, a decrease in the pulsatile frequency of TSH secretion, resulting from reduced thyrotropin-re leasing hormone (TRH) release by the hypothalamus, may also occur. Several medications or clinical conditions that are commonly present in critically ill patients may be responsible for lowering serum concentrations of thyroid hormone. Among those who study the condition, the question of whether NTIS is a protective adaptation of the organism to illness or a maladaptive response to a stressful insult remains unanswered. In either case, thyroid hormone abnormalities are likely to play a role in the critically ill patient.However, there is currently no convincing evidence to suggest that restoring physiological thyroid hormone concentrations in unselected patients with NTIS would be beneficial.

摘要

在危重病期间,无已知甲状腺疾病史的患者可能会经历其血清甲状腺激素水平的多种改变。这些改变被称为病态甲状腺功能正常综合征或最近被称为非甲状腺疾病综合征 (NTIS)。NTIS 的实验室参数通常包括三碘甲状腺原氨酸 (T3) 的血清水平低、甲状腺素 (T4) 的血清水平正常或低和甲状腺刺激激素 (TSH) 的血清水平正常或低。甲状腺功能改变的程度与 NTIS 危重病患者的疾病严重程度及其结局相关。NTIS 涉及的发病机制包括甲状腺外组织中 T4 向 T3 的转化减少和甲状腺激素与血清蛋白结合的改变。在长时间的危重病情况下,由于下丘脑释放的促甲状腺激素释放激素 (TRH) 减少,TSH 分泌的脉冲频率可能会降低。几种在危重病患者中常见的药物或临床情况可能会导致甲状腺激素血清浓度降低。在研究该病症的人群中,NTIS 是机体对疾病的一种保护性适应还是对应激性损伤的适应性反应,这个问题仍然没有答案。在任何一种情况下,甲状腺激素异常都可能在危重病患者中发挥作用。然而,目前没有令人信服的证据表明,在未选择的 NTIS 患者中恢复生理甲状腺激素浓度会有益。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验